Edition:
United States

Health News

Merck wins European approval for first-ever Ebola vaccine

U.S. drugmaker Merck & Co Inc on Monday received approval from the European Commission to market (http://bit.ly/2NZ0QMB) its Ebola vaccine, less than a month after a European medicines panel backed the first-ever vaccine against the deadly virus.

Health Reform Watch